Urovant Sciences, Inc, based in Irvine, CA, is a global healthcare company dedicated to improving the health and well-being of people worldwide. With a focus on critical areas such as psychiatry, neurology, oncology, urology, women's health, rare disease, and cell gene therapy, Urovant drives innovation in treatments, science, and technology to address patient needs.
As a subsidiary of Sumitomo Pharma Co., Ltd, Urovant Sciences embodies the promise of combining technology and life-sciences expertise to deliver measurable improvements in patient outcomes. With a diverse pipeline of preclinical and clinical programs, Urovant is committed to fueling breakthroughs and providing patient-first solutions through a technology-driven approach.
Generated from the website